Funding Opportunity PAR-24-203 from the NIH Guide for Grants and Contracts. This NOFO will solicit R01 applications that propose studies in animal, cell culture, and/or human tissue models to elucidate the mechanisms by which COVID-19 interacts with and/or modulates AD/ADRD-relevant phenotypes. Either the model itself or the experimental readouts will be required to incorporate AD/ADRD risk factors, pathologies, or relevant comorbidities. To this end, proposals can focus on one or more of the following: - Mechanistic studies that address how COVID-19 impacts CNS pathology and cognitive outcomes when AD/ADRD pathology is already present (for example, in a model of AD/ADRD). - Mechanistic studies that address how COVID-19 accelerates AD/ADRD pathology and cognitive deficits in a prodromal model (early phase, pre-symptomatic). - Mechanistic studies that address how COVID-19 predisposes for AD/ADRD and/or interacts with relevant comorbid conditions and risk factors (cellular mechanisms that could potentially increase the risk for future AD/ADRD).

Funding Opportunity PAR-24-139 from the NIH Guide for Grants and Contracts. To support outstanding graduate students from diverse backgrounds, including those from groups underrepresented in biomedical, clinical, behavioral and social sciences, over the transition from predoctoral to postdoctoral research training.. This phased award program will facilitate completion of graduate PhD or dual degree clinician scientist programs (F99) and progression to mentored postdoctoral positions in dental, oral and craniofacial research (K00).

Notice NOT-MH-24-225 from the NIH Guide for Grants and Contracts

Notice NOT-NS-24-068 from the NIH Guide for Grants and Contracts

Notice NOT-MD-24-012 from the NIH Guide for Grants and Contracts

Notice NOT-HD-24-022 from the NIH Guide for Grants and Contracts

Notice NOT-HD-24-021 from the NIH Guide for Grants and Contracts

Negotiable: Oxford Nanopore Technologies: We are seeking a hardworking and experienced Software Engineer to join the Instrument Software team. Oxford, England

Notice NOT-OD-24-099 from the NIH Guide for Grants and Contracts

Notice NOT-HL-24-012 from the NIH Guide for Grants and Contracts

Notice NOT-OD-24-097 from the NIH Guide for Grants and Contracts

Notice NOT-EY-24-004 from the NIH Guide for Grants and Contracts

George Washington University: I. DEPARTMENT INFORMATION Job Description Summary: GW's Milken Institute School of Public Health is known for conducting cutting-edge research, con... Washington, Washington DC

George Washington University: I. DEPARTMENT INFORMATION Job Description Summary: Founded in 1824, the GW School of Medicine and Health Sciences (SMHS) is the 11th oldest medical... Washington, Washington DC

George Washington University: I. JOB OVERVIEW Job Description Summary: Founded in 1824, the GW School of Medicine and Health Sciences (SMHS) is the 11th oldest medical school in... Washington, Washington DC

George Washington University: I. DEPARTMENT INFORMATION Job Description Summary: Antibiotic Resistance Action Center at George Washington University Milken Institute School of P... Washington, Washington DC

Leidos: Are you looking for a career that will make an impact? The Leidos Health & Civil Sector is currently looking for a Bioinformatics Engineer to suppo... Frederick, Maryland

Integrated Resources, Inc: Job Title: Research Scientist - Bioinformatics III Job Location: Foster City, CA (Position can be 100% remote.) Job Duration: 12 Months+ Pay range:... Atlanta, Georgia

George Washington University: I. DEPARTMENT INFORMATION Job Description Summary: The George Washington University Milken Institute School of Public Health is seeking a Bioinform... Washington, Washington DC

Funding Opportunity PAR-24-168 from the NIH Guide for Grants and Contracts. The purpose of this Notice of Funding Opportunity (NOFO) is to reissue PAR-24-256 "Feasibility Trials of the NIH Music-based Interventions Toolkit for Brain Disorders of Aging (R34 Clinical Trial Required)" in order to support proof-of-concept feasibility trials guided by the NIH Music-based Interventions (MBI) Toolkit for research on brain disorders of aging. These early stage clinical trials will generate evidence supporting the validity of the NIH MBI Toolkits guiding principles as well as the necessary pilot data to assess the feasibility of the design for a subsequent clinical efficacy or effectiveness study (or pragmatic clinical trial) using music-based interventions in the context of brain disorders of aging, including but not limited to Alzheimers disease and Alzheimers disease-related dementias, Parkinsons disease, and stroke. The data collected should address gaps in scientific knowledge in order to facilitate development of a competitive large-scale clinical trial.